Key facts
- Notable investors include Rockstart, Capricorn Partners.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Aestuarium
- ·The full record, as it builds
Funding rounds
No funding rounds for Aestuarium are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aestuarium
Operator of a biotechnology platform intended to combat global water scarcity through sustainable desalination. The company offers a microbial-based water treatment method with controllable salt absorption and low energy requirements, enabling municipalities and water infrastructure providers to access clean water through environmentally friendly methods.
- Sector
- Healthcare
- HQ
- Maastricht, Netherlands
- Founded
- 2023
- Website
- aestuarium.nl/
- Ownership
- Privately Held (backing)
Aestuarium doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aestuarium shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aestuarium in its N-PORT filings yet. We sweep new filings monthly.